Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ocugen, Inc. (OCGN)

2.1   0.19 (9.95%) 05-16 08:26
Open: 1.95 Pre. Close: 1.91
High: 2.13 Low: 1.89
Volume: 8,940,336 Market Cap: 453(M)
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.13 - 2.14 2.14 - 2.15
Low: 1.87 - 1.88 1.88 - 1.89
Close: 2.08 - 2.1 2.1 - 2.12

Technical analysis

as of: 2022-05-16 7:50:27 AM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 2.93     One year: 3.55
Support: Support1: 1.67    Support2: 1.38
Resistance: Resistance1: 2.51    Resistance2: 3.03
Pivot: 2.18
Moving Average: MA(5): 2.01     MA(20): 2.27
MA(100): 3.3     MA(250): 5.92
MACD: MACD(12,26): -0.3     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 43.1     %D(3): 29
RSI: RSI(14): 41.1
52-week: High: 17.64  Low: 1.67
Average Vol(K): 3-Month: 11,248 (K)  10-Days: 7,959 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ OCGN ] has closed above bottom band by 38.2%. Bollinger Bands are 48.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 09 May 2022
Ocugen stock slips 8% as Chardan Capital cuts PT (NASDAQ:OCGN) - Seeking Alpha

Sun, 08 May 2022
Ocugen (NASDAQ:OCGN) versus Codiak BioSciences (NASDAQ:CDAK) Head to Head Review - Defense World

Fri, 06 May 2022
Ocugen, Inc. (OCGN) Q1 2022 Earnings Call Transcript - The Motley Fool

Thu, 28 Apr 2022
The FDA Just Sent Ocugen a Warning. Should Investors Care? - The Motley Fool

Wed, 27 Apr 2022
Where Will Ocugen Stock Be In 5 Years? - Seeking Alpha

Thu, 21 Apr 2022
Ocugen Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 0 (M)
% Held by Insiders 1.9919e+008 (%)
% Held by Institutions 1.9514e+008 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -5.1e+006
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.26
Profit Margin (%) 0
Operating Margin (%) 12
Return on Assets (ttm) 148
Return on Equity (ttm) 346.8
Qtrly Rev. Growth 0
Gross Profit (p.s.) -0.16
Sales Per Share 0
EBITDA (p.s.) -0.27
Qtrly Earnings Growth -4.597e+007
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value -8.31
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 5.43e+007
Forward Dividend 4.693e+007
Dividend Yield 2585710000%
Dividend Pay Date 2019-09-29
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.